Corcept Therapeutics Incorporated (CORT) Financial Ratios: P/E, ROE & More

Corcept Therapeutics Incorporated (CORT) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Corcept Therapeutics Incorporated had a P/E ratio of 37.29 (down from 37.78), return on equity of 15.0% (down from 23.8%), debt-to-equity of 0.01 (down from 0.01) and a current ratio of 2.92 (down from 3.35). A current ratio of 2.92 means current assets exceed current liabilities.

Corcept Therapeutics Incorporated Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income Statement Balance Sheet Cash Flow Ratios

Scroll to see more

Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Valuation Ratios
P/E Ratio	37.29	37.78	31.74	21.59	18.64	28.67
Forward P/E	55.53	32.11	32.61	19.95	21.01	32.91
P/S Ratio	4.81	7.82	6.94	5.44	5.73	8.59
P/B Ratio	5.65	7.77	6.61	4.36	5.58	5.81
Price/Tangible Book	5.65	7.77	6.61	4.36	5.58	5.81
Price/FCF	25.82	26.92	26.46	18.23	12.53	20.16
Price/OCF	25.78	26.63	26.43	18.17	12.49	20.00
PEG Ratio	1.96	1.96	1.96	1.96	1.50	-
Enterprise Value Ratios
EV/Revenue	4.13	7.02	6.08	4.45	4.38	7.34
EV/EBITDA	68.40	34.40	27.08	15.69	12.73	20.18
EV/EBIT	70.15	34.60	27.34	15.87	12.88	20.26
EV/FCF	22.16	24.16	23.18	14.90	9.58	17.23
Profitability & Returns
Return on Equity (ROE)	15.02%	23.81%	21.05%	23.11%	25.03%	23.70%
Return on Assets (ROA)	3.34%	11.71%	11.13%	13.98%	15.63%	16.29%
Return on Invested Capital (ROIC)	15.32%	54.21%	87.09%	87.74%	94.15%	112.33%
Return on Capital Employed (ROCE)	6.70%	19.60%	20.80%	22.00%	33.10%	24.50%
Leverage & Solvency Ratios
Debt/Equity	0.01	0.01	0.00	0.00	0.00	0.01
Debt/EBITDA	0.13	0.05	0.00	0.01	0.00	0.02
Debt/FCF	0.04	0.04	0.00	0.01	0.00	0.02
Liquidity Ratios
Current Ratio	2.92	3.35	4.39	6.89	5.61	10.07
Quick Ratio	2.60	3.11	4.05	6.60	5.31	9.86
Efficiency Ratios
Asset Turnover	0.91	0.92	0.80	0.80	0.73	0.72
Inventory Turnover	1.03	1.08	0.94	0.97	1.07	1.08
Yield & Distribution Ratios
Earnings Yield	2.72%	2.68%	3.17%	4.64%	5.36%	3.49%
FCF Yield	3.87%	3.72%	3.78%	5.48%	7.98%	4.96%
Buyback Yield	-5.73%	-1.55%	3.64%	7.94%	-1.42%	-1.33%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Corcept Therapeutics Incorporated Financial Ratios

What is Corcept Therapeutics Incorporated's P/E ratio?

Corcept Therapeutics Incorporated's P/E ratio was 37.29 for fiscal 2025 (period ended Dec 31, 2025). It was 37.78 a year earlier.

What is Corcept Therapeutics Incorporated's return on equity?

Corcept Therapeutics Incorporated's return on equity (ROE) was 15.0% for fiscal 2025 (period ended Dec 31, 2025). It was 23.8% a year earlier.

What is Corcept Therapeutics Incorporated's debt-to-equity ratio?

Corcept Therapeutics Incorporated's debt-to-equity ratio was 0.01 for fiscal 2025 (period ended Dec 31, 2025). It was 0.01 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition